A promising strategy against SARS-CoV-2: pyrimidine inhibitors synergize with nucleoside analogues.

Min, Long; Sun, Qiu

Min, Long; Sun, Qiu.

Min L; State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, 610041, Chengdu, China.
Sun Q; State Key Laboratory of Biotherapy, Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center for Biotherapy, 610041, Chengdu, China. sunqiu@scu.edu.cn.

Signal Transduct Target Ther ; 7(1): 88, 2022 03 15.

Article in English | MEDLINE | ID: covidwho-1747248

Subject(s)

COVID-19 Drug Treatment; Nucleosides; Humans; Nucleosides/pharmacology; Pyrimidines/pharmacology; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Nucleosides Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2022 Document Type: Article Affiliation country: S41392-022-00956-6

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google